Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Termino C 12883 AB
AB
Dissolved
Org 5594463902
Retail sale of pharmaceutical products
· NACE 4773
Est. 2023
1 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Termino C 12883 AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
SEK thousands
Item
2024
Revenue
610
Staff expenses
−260
EBITDA
275
Depreciation & amort.
—
EBIT
275
Net financials
4
Profit before tax
279
Tax
−57
Net profit
222
Balance sheet
SEK thousands
Item
2024
Total assets
448
Equity
247
Long-term debt
—
Short-term debt
201
Total debt
201
Financial ratios
5-year trend
EBITDA margin
45.1%
This company
15.8%
Market median
+185% vs market
2024
2024
Equity ratio
55.0%
This company
38.2%
Market median
+44% vs market
2024
2024
Return on equity
89.9%
This company
18.4%
Market median
+389% vs market
2024
2024
Net profit margin
36.4%
This company
8.1%
Market median
+349% vs market
2024
2024
Asset turnover
1.36×
This company
1.12×
Market median
+21% vs market
2024
2024
Debt / equity
0.82×
This company
0.62×
Market median
+32% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-08-30 – 2024-12-31
View
PDF
More on Termino C 12883 AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot